Source: GlobalNewswire

Press Release: SWK : Opiant Pharmaceuticals, Inc. Announces Additional $3.75 Million Payment From NARCAN® Nasal Spray Royalty Monetization

Company Received Additional Payment From SWK Funding LLC Based on Achievement of $25 Million Net Sales of NARCAN® Nasal Spray Milestone

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Employees
CEO Avatar

CEO

Winston Black

CEO Approval Rating

79/100

SWK is a finance company that provides capital to a range of life science companies, institutions and inventors. Read more